Sequenom, Inc. (SQNM) Posts Q2 Loss of 27c/Share; Issues MaterniT21 PLUS Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
Go back to Sequenom, Inc. (SQNM) Posts Q2 Loss of 27c/Share; Issues MaterniT21 PLUS Update
July 25, 2013 9:43 AM EDT
Wedbush today maintained an Outperform rating on Sequenom (NASDAQ: SQNM) with a price target of $5.00. Shares tumbled as a result of disappointing earnings on Wednesday. Along with many other companies in the diagnostics industry, Sequenom experienced delays in receipt of payments as a result of... More
July 25, 2013 8:24 AM EDT
Ladenburg Thalmann downgraded Sequenom (NASDAQ: SQNM) from Buy to Neutral.
For an analyst ratings summary and ratings history on Sequenom click here. For more ratings news on Sequenom click here.
Shares of Sequenom closed at $4.69 yesterday, with a 52 week range of $2.65-$5.36.... More
July 25, 2013 7:17 AM EDT
William Blair downgraded Sequenom (NASDAQ: SQNM) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Sequenom click here. For more ratings news on Sequenom click here.
Shares of Sequenom closed at $4.69 yesterday, with a 52 week range of $2.65-$5.36.... More
July 25, 2013 7:16 AM EDT
Lazard Capital downgraded Sequenom (NASDAQ: SQNM) from Buy to Neutral.
For an analyst ratings summary and ratings history on Sequenom click here. For more ratings news on Sequenom click here.
Shares of Sequenom closed at $4.69 yesterday, with a 52 week range of $2.65-$5.36.... More
July 24, 2013 4:01 PM EDT
Sequenom, Inc. (NASDAQ: SQNM) trading halted with news pending..... More
